SCHEMBL4490437

SCHEMBL4490437

CN(C)C(=O)Nc1ccc(OCCCN2CC3CCCC3C2)cc1

nearest known ligand 0.61

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 10/20 0.61
EPHX2 P34913 4/20 0.47
HTR2A P28223 1/20 0.45
DRD2 P14416 1/20 0.44
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4500729 0.87 HRH3 (0.65) HRH3EPHX2HTR2ADRD2MAPT
Oxalic Acid SCHEMBL4497957 0.84 HRH3 (0.61) HRH3HTR2ADRD2MAPT
SCHEMBL4502312 0.84 HRH3 (0.61) HRH3EPHX2DRD2
SCHEMBL4622216 0.84 HRH3 (0.61) HRH3EPHX2HTR2ADRD2
SCHEMBL4485900 0.84 HRH3 (0.63) HRH3EPHX2MAPT
SCHEMBL4487976 0.84 HRH3 (0.63) HRH3EPHX2MAPT
SCHEMBL4622474 0.83 HRH3 (0.60) HRH3EPHX2MAPT
SCHEMBL4489369 0.82 HRH3 (0.72) HRH3
SCHEMBL1978870 0.82 DRD2 (0.60) HRH3HTR2ADRD2MAPT
SCHEMBL4489678 0.82 HRH3 (0.61) HRH3EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7576120-B2 Azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2009-08-18 US disclosed
EP-1720544-B1 NOVEL AZABICYCLIC DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME SERVIER LAB (FR) 2008-03-19 EP disclosed
US-20070197625-A1 Azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them. LES LABORATORATIES SERVIER (FR) 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197625-A1 Azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them. HRH2, HNMT, HRH1 HRH3 9/4885EPHX2 446/4885HTR2A 131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.